HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Podcast All Versions of this Article: 01.wnl.0000271880.27321.a7v1 69/22/2093    most recent Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klein, C. Articles by Schlossmacher, M. G. Search for Related Content PubMed PubMed Citation Articles by Klein, C. Articles by Schlossmacher, M. G. Related Collections Parkinson's disease/Parkinsonism Gene expression studies All Genetics Genetic linkage Association studies in genetics

Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder

From the Department of Neurology (C.K.), University of Lübeck, Germany; and OHRI–Division of Neuroscience (M.G.S.), University of Ottawa, Ontario, Canada.

Address correspondence and reprint requests to Dr. C. Klein, Department of Neurology, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany christine.klein{at}neuro.uni-leubeck.de; and Dr. M. Schlossmacher, OHRI-Neuroscience, University of Ottawa, 451 Smyth Road, Ottawa, Ontario K1H 8M5 Canada mschlossmacher{at}ohri.ca

Over the last 10 years, an unprecedented number of scientific reports have been published that relate to the pathogenesis of parkinsonism. Since the discovery in 1997 of the first heritable form of parkinsonism that could be linked to a mutation in a single gene, SNCA, many more genetic leads have followed (Parkin, DJ-1, PINK1, LRRK2, to name a few); these have provided us with many molecular clues to better explore the etiology of parkinsonism and have led to the dismantling of many previously held dogmas about Parkinson disease (PD). Epidemiologic studies have delineated an array of environmental modulators of susceptibility to parkinsonism, which can now be examined in the context of gene expression. Furthermore, in vivo imaging data and postmortem results have generated concepts that greatly expanded our appreciation for the phenotypic spectrum of parkinsonism from its presymptomatic to advanced stages. With this plethora of new information emerged the picture of a complex syndrome that raises many questions: How many forms of classic parkinsonism/Parkinson disease(s) are there? Where does the disease begin? What causes late-onset, "idiopathic" PD? What are the caveats related to genetic testing? What is the role of Lewy bodies? What will be the best disease model to accommodate the now known genetic and environmental contributors to parkinsonism? What will be the ideal markers and targets for earlier diagnosis and cause-directed therapy? In the following article we highlight some of the burning issues surrounding the understanding of classic parkinsonism, a complex puzzle of genes, environment, and an aging host.

e-Pub ahead of print on August 29, 2007, at www.neurology.org.

Disclosure: The authors report no conflicts of interest.

This article has been cited by other articles:

				K. Marek and D. Jennings Can we image premotor Parkinson disease? Neurology, February 17, 2009; 72(7_Supplement_2): S21 - S26. [Abstract] [Full Text] [PDF]

				Weidong Le, Shen Chen, and J. Jankovic Etiopathogenesis of Parkinson Disease: A New Beginning? Neuroscientist, February 1, 2009; 15(1): 28 - 35. [Abstract] [PDF]

				C. Klein and K. Lohmann Parkinson disease(s): Is "Parkin disease" a distinct clinical entity? Neurology, January 13, 2009; 72(2): 106 - 107. [Full Text] [PDF]

				O. A. Ross, M. Toft, K. Haugarvoll, A. Chen-Plotkin, W. Yuan, C. Anderson, E. M. Wood, H.I. Hurtig, C. Clark, B.L. Miller, et al. CORTICOBASAL SYNDROME AND PRIMARY PROGRESSIVE APHASIA AS MANIFESTATIONS OF LRRK2 GENE MUTATIONS Neurology, July 22, 2008; 71(4): 303 - 304. [Full Text] [PDF]

				E. Kyratzi, M. Pavlaki, and L. Stefanis The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells Hum. Mol. Genet., July 15, 2008; 17(14): 2160 - 2171. [Abstract] [Full Text] [PDF]

				A. Hurtado-Lorenzo and V. S. Anand Heat Shock Protein 90 Modulates LRRK2 Stability: Potential Implications for Parkinson's Disease Treatment J. Neurosci., July 2, 2008; 28(27): 6757 - 6759. [Full Text] [PDF]